First human trial to use embryonic-like stem cells collected from adult cells to grow bone

Researchers at the University of Michigan School of Dentistry and New York-based NeoStem Inc. are ready for the first known human trial to use embryonic-like stem cells collected from adult cells to grow bone. The VSEL stem cell technology is derived from adults, not fetuses, which eliminates ethical arguments associated with using embryonic stem cells.

The researchers say that the stem cell technology can provide a minimally invasive way to speed painful bone regeneration for dental patients and others with bone trauma. "Within a year, researchers hope to begin recruiting roughly 50 patients who need a tooth extraction and a dental implant," University of Michigan dental professor Russell Taichman said. Robin Smith, chairman and CEO of NeoStem, emphasized the importance of this study for the development of embryonic-like stem cells from the patient's own body to treat a wide range of diseases.

Read more about the study from News Track India.